Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Zhengrui Pharmaceutical Technology Development is a pharmaceutical research and development enterprise based in Haikou, China. The company specializes in the development of high-end generic drugs and the optimization of pharmaceutical formulations across various therapeutic areas, including oncology, cardiovascular diseases, and metabolic disorders. Their core business involves drug synthesis, quality control research, and navigating the regulatory approval process for the Chinese market. By focusing on technology transfer and collaborative R&D, the company supports the commercialization of cost-effective therapeutic alternatives. They have successfully developed several small molecule products that have reached the commercial stage through partnerships with manufacturing entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Zhengrui Pharmaceutical Technology Development.